Dataset from A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild or Asymptomatic COVID-19
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00010066
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this study is to evaluate the efficacy of oral favipiravir plus standard of
care treatment (SOC) compared with placebo plus SOC in reducing the duration of shedding of
SARS-CoV2 virus in patients with mild or asymptomatic COVID-19.
创建时间：
2026-02-06
